Skip to main content
Critical Care Reviews Newsletter logo

Newsletter 764  |  August 3rd, 2026

Nothing to Lose Fallacy infographic

Welcome to the 764th Critical Care Reviews Newsletter, bringing you the best critical care research and open access articles from across the medical literature over the past seven days. 

The highlights of this week's edition are randomised controlled trials on dapagliflozin and acute kidney injury following cardiac surgery & prone positioning in infants with acute bronchiolitis; systematic reviews and meta analyses on anabolic androgen therapy in critically ill adults & albumin for people with liver cirrhosis and bacterial infections; and observational studies on rocuronium dose and first-attempt intubation success in the critically ill & video versus direct laryngoscopy for tracheal intubation in trauma

There are also guidelines on acute-on-chronic liver failure & candidemia and invasive candidiasis; narrative reviews on antiseizure medication dosing and monitoring in the intensive care unit & mechanical ventilation – physiology, mechanism and modes; editorials on oxygen exposure in patients with brain injury: beyond static thresholds & questions that remain for Impella use in ST-elevation myocardial infarction; and commentaries on interpreting protein dose trials in critical illness & optimizing endpoints in early phase clinical trials of acute respiratory distress syndrome

If you only have time to read one review article this week, try this one on twenty-five years of septic shock hemodynamic resuscitation trials: a conceptual perspective

Critical Care Reviews Blog

Our latest blog was published last week - The Nothing-to-Lose Fallacy.

Research

Randomised Controlled Trials 

Systematic Reviews & Meta Analyses 

Observational Studies 

Reviews

Clinical

Neurological
Circulation
Resuscitation
Airway 
Respiratory
Liver 
Renal
Sepsis & Infectious Disease
Trauma
Metabolic
Perioperative
Toxicology
Paediatrics & Neonatology
Artificial Intelligence
Miscellaneous

Correspondence

I hope you find this newsletter useful.


Until next week

Rob

 

Critical Care Reviews is a not-for-profit evidence dissemination platform.
Newsletter subscriptions directly support our work and make it sustainable.
Individual and unit subscriptions are available here.

 

🔴 You can update your subscription on the menu > newsletters > my subscription.